NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
3.990
+0.070 (1.79%)
At close: Dec 12, 2025, 4:00 PM EST
4.009
+0.019 (0.48%)
Pre-market: Dec 15, 2025, 8:45 AM EST
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $459.91 million as of December 15, 2025. Its market cap has increased by 496.37% in one year.
Market Cap
459.91M
Enterprise Value
297.78M
1-Year Change
496.37%
Ranking
Category
Stock Price
$3.99
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $459.91M, an increase of 233.15%. That is a compound annual growth rate of 22.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 459.91M | 564.43% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |